Murat Ayhan
- Specializzazione: Clinical oncologist
- 12 anni di esperienza
- Lingue parlate:English
- Consultazioni online: disponibili
- Studio medico: Turchia, Istanbul, Liv Hospital Vadistanbul
- Member of the European Society for Medical Oncology (ESMO) and principal investigator in global Phase II and III oncology clinical trials.
Dr. Murat Ayhan is an associate professor of medical oncology at Liv Hospital Vadistanbul. He is an expert in treating breast, lung, colorectal, and urogenital cancers. Dr. Ayhan focuses on immunotherapy and targeted therapies. He provides personalized care for patients with adenocarcinoma and osteosarcoma. Dr. Ayhan works at a JCI-accredited facility in Istanbul.
- Principal investigator in global Phase II and III clinical oncology trials.
- Active member of the European Society for Medical Oncology (ESMO).
- Published over 25 articles in international scientific journals.
- Authored medical book chapters on tyrosine kinase inhibitors and oncology emergencies.
Consulto medico online con Murat Ayhan
Recensioni dei pazienti
Servizi medici
Com'è andata la tua esperienza?
Formazione accademica
Dr. Murat Ayhan is an Associate Professor of Medical Oncology at Liv Hospital Vadistanbul. He treats patients using immunotherapy and targeted drugs for cancers. He is a principal investigator for global Phase II and III clinical trials.
Oncology Specialization
Dr. Ayhan treats a wide range of solid tumors. He helps patients with breast, lung, and colorectal cancers. He also treats gynecological and urogenital malignancies. He uses molecular oncology to create treatment plans for each patient. His methods include:
- Immunotherapy
- Targeted Therapy
- Hormone therapy
- Chemotherapy
- Rapid drug desensitization – a method to safely give medication to patients who have had allergic reactions
Clinical Research and Trials
Dr. Ayhan leads international studies to improve cancer care. He investigates new therapies for metastatic breast and lung cancers. His work includes research on drugs such as Atezolizumab and Palbociclib. He studied how COVID–19 affects cancer patient mortality. Additionally, he researches PET/CT imaging to predict chemotherapy success.
Work Experience
- Liv Hospital Vadistanbul
- Adıyaman University Training and Research Hospital
- Istanbul Umraniye Training and Research Hospital
Education and Academic Background
- 2007 – Dicle University, Faculty of Medicine – Medical Degree
- 2014 – Istanbul Medeniyet University Göztepe Hospital – Residency
- 2021 – Kartal City Hospital – Specialized Oncology Training
- 2023 – Associate Professor of Medical Oncology
Publications and Authorship
Dr. Ayhan has published 25 articles in international journals. He also authors chapters in oncology reference books. Notable works include:
- "Small molecule tyrosine kinase inhibitors" in Turkish Clinics Journal (2021)
- "Oncological emergencies" in Internal Medicine Emergencies (2022)
- "Medical approach in primary non-gastrointestinal neuroendocrine tumors" (2020)
- "Survival analysis of patients with triple-negative breast cancer" (2022)
Professional Memberships
- European Society for Medical Oncology (ESMO)
- Turkish Society of Medical Oncology (TTOD)
Potrebbe interessarti anche
Pagamenti e Benefici
I nostri servizi sono gratuiti
Il pagamento viene effettuato direttamente presso la clinica oppure tramite bonifico sul loro conto bancario ufficiale.
Alcune cliniche possono richiedere un deposito come parte della loro politica.
Paghi comodamente a rate flessibili.
Ricevi premi per raccomandare Bookimed ai tuoi amici.